Author:
Gieschke Ronald,Serafin Daniel
Publisher
Springer Berlin Heidelberg
Reference5 articles.
1. Hale M, Gillespie WR, Gupta S, Tuk B, Holford NH (1995) Clinical trial simulation. Streamlining your drug development process. Appl Clin Trials 5:35–40
2. Johnson SCD (1998) The role of simulation in the management of research: what can the pharmaceutical industry learn from the aerospace industry? Drug Inf J 32:961–969
3. Lee JY, Garnett CE, Gobburu JVS, Bhattaram VA, Brar S, Earp JC, Jadhav PR, Krudys K, Lesko LJ, Li F, Liu J, Madabushi R, Marathe A, Mehrotra N, Tornoe C, Wang Y, Zhu H (2000) Impact of pharmacometric analyses on new drug approval and labelling decisions. A review of 198 submissions between, and 2008. Clin Pharmacokinet 50:627–635
4. Chanu P, Gieschke R, Charoin JE, Pannier A, Reigner B (2010) Population pharmacokinetic/pharmacodynamic model for C.E.R.A. in both ESA-naïve and ESA-treated chronic kidney disease patients with renal anemia. J Clin Pharmacol 50:507–520
5. Garred LJ, Pretlac R (1991) Mathematical modeling of erythropoietin therapy. ASAIO J 37:M457–M459